Facts of VIEKIRA PAK ?

  • Medicine Name: VIEKIRA PAK
  • Generic Name: Ombitasvir, Paritaprevir, and Ritonavir Tablets; Dasabuvir Tablets
  • Date of Approval: 19 December 2014
  • Company Name: AbbVie Inc., North Chicago


VIEKIRA PAK is a prescription medicine used with or without ribavirin to treat people with genotype 1 chronic (lasting a long time) hepatitis C virus (HCV) infection, including people who have a certain type of cirrhosis (compensated).

VIEKIRA PAK is not for people with advanced cirrhosis (decompensated). If you have cirrhosis, talk to your healthcare provider before taking VIEKIRA PAK.

VIEKIRA PAK contains 2 different types of tablets. You must take both types of tablets exactly as prescribed, to treat your chronic hepatitis Cvirus (HCV) infection.

  • the pink tablet contains: the medicines ombitasvir, paritaprevir, and ritonavir
  • the beige tablet contains: the medicine dasabuvir

It is not known if VIEKIRA PAK is safe and effective in children under 18years of age.

If you take VIEKIRA PAK with ribavirin, you should also read the Medication Guide for ribavirin.

How supplied/storage and handling ?

VIEKIRA PAK is dispensed in a monthly carton for a total of 28 days of therapy. Each monthlycarton contains four weekly cartons. Each weekly carton contains seven daily dose packs.

Each child resistant daily dose pack contains four tablets: two 12.5/75/50 mg ombitasvir,paritaprevir, ritonavir tablets and two 250 mg dasabuvir tablets, and indicates which tablets needto be taken in the morning and evening. The NDC number is NDC 0074-3093-28.

Ombitasvir, paritaprevir, ritonavir 12.5/75/50 mg tablets are pink-colored, film-coated, oblongbiconvex shaped, debossed with “AV1” on one side. Dasabuvir 250 mg tablets are beige-colored,film-coated, oval-shaped, debossed with “AV2” on one side.

Store at or below 30°C (86°F).